Aesica Expands Oral Solids Capability at German Facility - - BioPharm International

ADVERTISEMENT

Aesica Expands Oral Solids Capability at German Facility



Aesica Pharmaceuticals, a CDMO, is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau, Germany.

The new roller compaction unit uses a continuous production step that enhances product uniformity and has been undertaken following a market demand for pharmaceutical formulation technologies that enable the formulation of APIs otherwise inhibited by the presence of water.

Source: Aesica Pharmaceuticals

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

Suppliers Seek to Boost Single-Use Technology
August 21, 2014
Bristol-Myers Squibb and Celgene Collaborate on Immunotherapy and Chemotherapy Combination Regimen
August 20, 2014
USP Center in Ghana Receives International Lab Accreditation
August 15, 2014
USP Awards Analytical Research
August 15, 2014
FDA Warns about Fraudulent Ebola Treatments
August 15, 2014
Author Guidelines

Click here